Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 16 studies | 24% ± 7% | |
mesothelial cell | 6 studies | 36% ± 11% | |
adventitial cell | 5 studies | 25% ± 10% | |
glutamatergic neuron | 4 studies | 26% ± 14% | |
GABAergic neuron | 3 studies | 19% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 25% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 99% | 3583.29 | 456 / 459 | 94% | 15.98 | 1047 / 1118 |
brain | 87% | 1477.70 | 2298 / 2642 | 99% | 40.51 | 699 / 705 |
lung | 99% | 3798.50 | 571 / 578 | 87% | 12.38 | 1006 / 1155 |
prostate | 98% | 2516.46 | 239 / 245 | 78% | 5.63 | 393 / 502 |
skin | 82% | 2993.83 | 1488 / 1809 | 84% | 18.24 | 398 / 472 |
uterus | 99% | 3026.08 | 169 / 170 | 66% | 11.25 | 302 / 459 |
ovary | 100% | 4839.86 | 180 / 180 | 59% | 5.66 | 255 / 430 |
bladder | 95% | 4254.52 | 20 / 21 | 54% | 8.85 | 273 / 504 |
esophagus | 80% | 2353.20 | 1152 / 1445 | 64% | 9.21 | 118 / 183 |
thymus | 94% | 1768.82 | 615 / 653 | 42% | 3.53 | 257 / 605 |
intestine | 87% | 2129.56 | 836 / 966 | 48% | 8.08 | 251 / 527 |
pancreas | 27% | 269.86 | 87 / 328 | 90% | 26.53 | 160 / 178 |
stomach | 57% | 1871.85 | 203 / 359 | 58% | 6.52 | 165 / 286 |
adrenal gland | 74% | 888.36 | 191 / 258 | 34% | 4.39 | 79 / 230 |
kidney | 55% | 761.10 | 49 / 89 | 51% | 7.14 | 456 / 901 |
adipose | 100% | 9685.56 | 1203 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 10.16 | 75 / 80 |
heart | 88% | 2366.64 | 756 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 87% | 1890.23 | 1164 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 8.68 | 22 / 29 |
tonsil | 0% | 0 | 0 / 0 | 67% | 9.08 | 30 / 45 |
liver | 4% | 45.17 | 10 / 226 | 19% | 1.93 | 78 / 406 |
muscle | 20% | 197.01 | 159 / 803 | 0% | 0 | 0 / 0 |
spleen | 13% | 118.20 | 31 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 25.68 | 13 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006048 | Biological process | UDP-N-acetylglucosamine biosynthetic process |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0006002 | Biological process | fructose 6-phosphate metabolic process |
GO_0006541 | Biological process | glutamine metabolic process |
GO_0006047 | Biological process | UDP-N-acetylglucosamine metabolic process |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0006112 | Biological process | energy reserve metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005515 | Molecular function | protein binding |
GO_0004360 | Molecular function | glutamine-fructose-6-phosphate transaminase (isomerizing) activity |
GO_0097367 | Molecular function | carbohydrate derivative binding |
Gene name | GFPT2 |
Protein name | glutamine--fructose-6-phosphate transaminase (isomerizing) (EC 2.6.1.16) Glutamine-fructose-6-phosphate transaminase 2 Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 2) (Glutamine:fructose-6-phosphate amidotransferase 2) (GFAT 2) (GFAT2) (Hexosephosphate aminotransferase 2) |
Synonyms | hCG_15277 |
Description | FUNCTION: Controls the flux of glucose into the hexosamine pathway. Most likely involved in regulating the availability of precursors for N- and O-linked glycosylation of proteins. |
Accessions | A0A0S2Z4X9 D6RAC1 ENST00000253778.13 ENST00000518906.1 ENST00000503228.1 E5RJP4 A0A0S2Z4W6 O94808 |